PSI Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PSI Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$22K	–	664
2019 Q4	$22K	Buy	+500	New	+$23.6K	0.01%	368

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

PSI Advisors's ARNA Position: Q1 2020 in Review

PSI Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 500 shares — an estimated $22K sold.

PSI Advisors first reported a position in ARNA in Q4 2019 and held it in 1 quarter. The position peaked at $22K in Q4 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

PSI Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
PSI Advisors sold 500 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $22K.
PSI Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 1 quarter.
PSI Advisors's Arena Pharmaceuticals Inc position peaked at $22K in Q4 2019.
219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on PSI Advisors's 13F filing for Q1 2020, filed 15 May 2020.